Some observations on the use of the morantel sustained-release bolus in first season-grazing calves on a Belgian dairy cattle farm

The efficacy of the morantel sustained-release bolus (MSRB) in controlling gastrointestinal parasites in first-season grazing calves was evaluated on a dairy cattle farm in Belgium. The calves grazed a pasture which had been used by bolus-treated animals in the three previous years. The effect of bolus administration was determined with respect to live weight gain, faecal egg shedding, herbage larval counts, serum pepsinogen levels and ELISA antibody titres. In spite of an incomplete reduction of faecal egg shedding during the first months of the grazing season, bolus administration resulted in the prevention of parasitic gastro-enteritis in the calves. A weight gain advantage of 35,2 kg of the bolus-treated animals over the controls was noted already at two months after turnout. This weight gain advantage was maintained until housing. The usefulness of serum pepsinogen values and ELISA antibody titres as parameters in prevention experiments is stressed. Both serological parameters gave more information concerning infection level than did the faecal egg output and the herbage larval counts.     

Ostertagiasis in calves. I. The effect of control measures on infection levels and body weight gains during the grazing season in Denmark

The investigation was designed to study the gastro-intestinal helminth infection established in yearling calves with reference to fluctuations in the larval contamination of the herbage during the grazing season. In a 2 × 3 factor experiment, comprising six groups, each of six calves, a comparison was made between infection levels, growth rates etc. in calves grazing the same paddock over an entire season and calves moved before the July rise in herbage contamination to paddocks not grazed earlier in the same season. A comparison was also made between animals receiving no anthelminthic treatment, animals treated 3 weeks after the start of the grazing season and again when moved, and animals treated every 3 weeks during the season.Before July there were no weight gain differences between the various groups of calves. During the rest of the season, the calves which were moved gained 647–869 g, while those that remained on the same paddock, and were exposed to a high level of larval contamination gained only 81–361 g per day. The effect of anthelmintic treatment was less pronounced, though significant. The weight gains were correlated to a high degree with the larval contamination levels of the respective paddocks (r = ? 0.79) as well as with the serum pepsinogen (r = ? 0.75) and albumin levels (r = 0.75) of the calves and to a minor degree also with faecal egg counts (r = ? 0.45). The observed weight gain differences could not be accounted for by differences in grass quantity or quality.     

Some observations on the use of the morantel sustained‐release bolus in first season‐grazing calves on a Belgian dairy cattle farm

Summary

The efficacy of the morantel sustained‐release bolus (MSRB) in controlling gastrointestinal parasites in first‐season grazing calves was evaluated on a dairy cattle farm in Belgium. The calves grazed a pasture which had been used by bolus‐treated animals in the three previous years. The effect of bolus administration was determined with respect to live weight gain, faecal egg shedding, herbage larval counts, serum pepsinogen levels and ELISA antibody titres.

In spite of an incomplete reduction of faecal egg shedding during the first months of the grazing season, bolus administration resulted in the prevention of parasitic gastro‐enteritis in the calves. A weight gain advantage of 35,2 kg of the bolus‐treated animals over the controls was noted already at two months after turnout. This weight gain advantage was maintained until housing.

The usefulness of serum pepsinogen values and ELISA antibody titres as parameters in prevention experiments is stressed. Both serological parameters gave more information concerning infection level than did the faecal egg output and the herbage larval counts.     

Effects of previous suppressive anthelmintic treatments on subsequent nematode infection in fattening cattle in Argentina

The effect of previous suppressive anthelmintic treatments after weaning on parasitological parameters and weight gain of cattle was studied in the Pampeana region of Argentina. The study was carried out at two grazing fattening periods: April 1995/July 1996 and April 1997/July 1998. During both periods, 60 weaned calves that grazed contaminated pastures, were divided into three groups during the first part of the periods: GY1 group was treated every 2 weeks with doramectin while GY2 and GY3 groups remained untreated. During the second part of the periods, from October onwards GY1 and GY2 remained untreated and GY3 was treated every 2 weeks. In this second period two new groups of 20 weaning young calves were added: TG (treated every 2 weeks) and UG (untreated). Egg counts (EPG), larval cultures, pasture larval counts, serum pepsinogen (Pep) and live weight gain (LWG) were recorded monthly. Ostertagia, Cooperia, Trichostrongylus and Haemonchus were the predominant genera. Despite low levels of previous infection during the first part of the period, slight differences of EPG between GY1 (P<0.09) or UG (P<0.05) and GY2 were detected in the second part of the fattening period in 1995/1996. In 1997/1998 moderate infection levels during the first part of the period were observed. During the second part of this period, GY1 and UG showed higher (P<0.001) EPG than GY2, and only GY3 and TG had (P<0.05) lower Pep levels. Also, during the second part of 1997/1998, LWG responses of GY3 were higher (P<0.001) than those of GY1 and GY2. Live weight gain of GY2 exceeded GY1 by 10.7kg (P<0.006). Higher EPG and lower LWG of GY1 suggest that suppressive treatments negatively affected the level of resistance to infection of yearlings, but these effects were influenced by previous levels of nematode infection. The lack of differences between yearling (GY1) and calves (UG) groups suggest that, under the conditions of this study, there was no evidence that resistance to infection and the related parameters are influenced by the age.     

Appetite, digestive efficiency, feed utilization and carcass evaluation of housed calves naturally infected with gastrointestinal nematodes

The progress of two groups of 10 calves, which had previously been exposed to trichostrongyle infections by grazing infected pastures, was monitored from housing in October to slaughter the following April. Each of the animals of one group had received a morantel sustained release bolus, the other control group remained untreated. The high faecal egg counts and serum pepsinogen concentrations, together with the clinical signs of ostertagiosis observed in the controls in October, persisted during the first month of housing but improved thereafter. From late November onwards, no difference in feed intake and digestive efficiency was observed between the groups. The control calves exhibited a significantly greater feed conversion efficiency over the period February-April, (7.5 vs. 12.3 kg feed kg-1 liveweight gain, P less than 0.001). This reduced the liveweight advantage of the MSRB group over the controls at housing to 25 kg.     

The determination at housing of exposure to gastrointestinal nematode infections in first-grazing season calves

Various parameter estimates were assessed at housing in calves that had been exposed to gastrointestinal nematodes during a first grazing season. The analysis involved 41 groups of first grazing season (FGS) calves on 15 different farms in Belgium and comprised groups that had received chemoprophylactic treatment and untreated controls. Serum pepsinogen levels gave the clearest division between chemoprophylactic-treated calf groups (all were <2.6 U tyr), and untreated calf groups in which sub-clinical (range: 2.0–4.1 U tyr) and clinical infections (range 3.7–6.3 U tyr) occurred. There was also a tight relationship between individual pepsinogen values and adult Ostertagia burdens obtained at slaughter. In chemoprophylactic-treated groups there was a significant negative relationship between mean serum pepsinogen levels at housing and the proportion of the grazing season covered by different chemoprophylactic systems. Although only limited data on crude adult Ostertagia antigen ELISA were available, a good relationship between optical densities and estimated exposure was also found. The parasitological parameters, faecal egg counts and pasture Ostertagia larval counts at housing, and weight gain per day, gave less clear divisions among the three categories (chemoprophylaxis, sub-clinical and clinical). Distinguishing how much exposure a calf group has experienced during a first grazing season could help in designing more appropriate control measures for the FGS calves in the next year, assuring good protection and at the same time allowing sufficient exposure for the development of acquired immunity to Ostertagia, and for this serum pepsinogen is recommended.     

Performance of second-season grazing cattle following different levels of parasite control in their first grazing season

A 3-year grazing trial was performed during 2003-2005 on a commercial steer-producing farm in Sweden to study performance of second-season grazing (SSG) cattle following different levels of parasite exposure during their first grazing season. Initially, groups of 10 first-season grazing (FSG) cattle were each year assigned to four parasite control strategies: (1) turn-out onto pasture that during the previous year was grazed by SSG cattle, followed by a mid-July move to aftermath, (2) supplementation with concentrate and roughage for 4 weeks after turn-out, (3) no treatment, or (4) anthelmintic treatment (injectable doramectin) every fourth week. All animals were set stocked, except for those in group one. Next spring and following housing the cattle were turned out for their second grazing season onto approximately 25 ha communal pasturelands as a common mob. Weighing, faecal sampling and blood collection were performed at turn-out and then every 4 weeks for the 20-week grazing season. Faecal samples were also collected on day 10 after turn-out for detection of coccidian oocysts. Antibodies to Dictyocaulus viviparus were analysed at the time of their second housing period, and when elevated levels were recorded, stored serum samples from seropositive animals were analysed retrospectively. Results showed early-season weight losses of up to 47 kg in the SSG cattle. However, faecal egg counts were generally low and there was no correlation between SSG performance and treatment history as FSG cattle. Still, cumulative egg counts were significantly higher in animals that had been treated with anthelmintic as FSG cattle but serum pepsinogen concentrations showed no significant differences and the output of Eimeria alabamensis oocysts seldom exceeded 10,000 oocysts per gram faeces. Antibodies to D. viviparus were observed from July 2004 and from June 2005 but not in 2003. In 2004 and 2005, 64% and 83% of the animals, respectively, were seropositive for D. viviparus. It is concluded that weight gain penalties resulting from different levels of parasite infections the first grazing season remained during the second grazing season in 2004 and 2005 but no differences in weight gain could be identified in SSG cattle that had experienced different parasite control measures during their first grazing season. This was under conditions where the level of pasture infectivity was low to moderate during the second grazing period. However, D. viviparus was demonstrated in SSG animals during the two last years of the study and was an important confounding factor.     

Control of gastrointestinal nematodes in first season grazing calves by two strategic treatments with eprinomectin

A study was carried out to evaluate the effects of strategic early-season treatments with eprinomectin on first-season grazing calves exposed to strongyle infections on a naturally contaminated pasture. Two groups of first grazing season (FGS) calves were turned out in mid-May on two plots that were similar with respect to size and herbage infectivity. They grazed separately until housing at the end of October. One of these groups was given eprinomectin pour-on at turnout and 8 weeks later, while the other group served as untreated controls. The results showed that the treatments reduced gastrointestinal strongyle infections throughout the season as evidenced by lower faecal egg counts and serum pepsinogen levels compared with the controls. Furthermore, the results of herbage larval counts and postmortem worm counts in tracer animals demonstrated that the treatment had reduced herbage infectivity on the 'treated' plot. Finally, the chemoprophylactically treated calves had a better weight gain over the duration of the study than the untreated controls.     

Field efficacy of a morantel sustained release bolus for control of gastrointestinal nematodes in yearling steers

The efficacy of a morantel sustained release bolus (MSRB) for control of gastrointestinal nematodes in yearling steers was evaluated over a 6-month grazing period commencing on 26 March 1982. Three groups of 15 steers were allotted to the following treatments: Group 1 -- one MSRB at start of trial; Group 2 -- one therapeutic dose of thiabendazole at start of trial; Group 3 -- untreated control. The treatment groups were grazed separately. Parasite egg counts (EPG), herbage larval counts, pepsinogen levels and weight gains were monitored. Every other month, sets of 2 parasite-free tracer calves were placed in the pasture grazed by each treatment group and allowed to graze for 3 weeks before being subsequently necropsied for worm counts. At the end of the trial, 6 animals from each group were also necropsied for worm counts. The MSRB treatment resulted in significantly lower egg counts, fewer infective larvae on pasture, lower pepsinogen levels and lower worm burdens in tracer calves than was the case for the untreated group, but generally the levels were not significantly different from those associated with the thiabendazole treatment. The mean weight gain for the MSRB treated steers showed a significant advantage (70.9 lb) over the untreated animals, but was not significantly different from those which received thiabendazole. Total worm counts at the end of the trial were not different from any treatment group.     

Diagnostic value of gastrin for clinical bovine ostertagiosis.

Gastrin values were evaluated in 130 parasite naive calves, in 61 first season grazing calves during six field trials and in 8 experimentally infected adult immune cows. The gastrin values were linked to pepsinogen levels and daily weight gain. Also the influence of an anthelmintic treatment on pepsinogen and gastrin values was assessed during a clinical outbreak of ostertagiosis in a group of first season grazing calves. Mean gastrin levels in parasite naive calves were 106 pg/ml. Results show that a group mean of 400 pg/ml gastrin in first season grazing calves indicates a reduced daily weight gain but with no obvious clinical signs. During clinical outbreaks mean gastrin levels frequently reached 1,000 pg/ml with a severe weight loss and a mean pepsinogen level of 5,000 mU tyr. The serum gastrin concentration was strongly reduced 4 days post treatment. No gastrin response was noted following an Ostertagia challenge in adult immune cows. The value of gastrin as a diagnostic aid for ostertagiosis is discussed in relation to pepsinogen, the adult worm burden, larval inhibition and the technique involved in assessing gastrin.     

Effects of the use of a morantel sustained release bolus in first and second year grazing cattle

In an experiment carried out in 1981 and 1982, the effect of the use of a morantel sustained release bolus (Paratect bolus) on the weight gain and a number of parasitological parameters of cattle was studied. In the first year 42 calves were divided into 3 equal groups, one group was kept outside and treated with a bolus (B), the second group was kept outside and was not treated (C), while the third group remained indoors (I). Groups B and C were grazed separately on contaminated pasture. During the first months Group B had a negligible egg output. The egg output in the controls was much higher and in mid-August they had to be treated for parasitic gastroenteritis. At the end of the grazing season the advantage in weight gain of Group B was 20 kg compared with the controls. During the housing period the growth in the 3 groups was not significantly different. At the start of the second grazing season half the animals of Groups B, C and I received a bolus (Groups BB, CB and IB). The other half remained untreated (BC, CC and IC). The animals treated with a bolus in 1982 gained significantly more weight (64 g/day) than untreated animals. Heifers turned out for the first time (IB and IC) showed much less weight gain than heifers in their second grazing season. The heifers which had previously grazed in 1981 had a very low egg output compared with Groups IB and IC, although the level of egg output of the latter was also not very high (max, almost 40 (eggs per gram (EPG)). In faecal cultures of heifers of Group BC, CB and CC, no Cooperia oncophora-larvae were seen from May onwards, indicating a strong immunity against this species. In Group BB very low numbers of C. oncophora-larvae were observed. In Groups IB and IC, C. oncophora was present during the whole season. At the end of the first season the level of herbage infestation on the control pastures was much higher. In 1982 only slight differences in level of infestation between the pastures were observed. At the start of the season in 1982 serum pepsinogen levels were much higher in the groups which grazed in 1981, compared with the indoor-fed groups. Groups BC and CC had significantly higher levels than Groups BB and CB and all 4 groups always had higher levels than Groups IB and IC.(ABSTRACT TRUNCATED AT 400 WORDS)     

Comparison of a levamisole sustained-release bolus and ivermectin treatment to prevent bovine lungworm infection

The efficacy of a levamisole sustained-release bolus to prevent parasitic bronchitis in calves in their first grazing season was compared to ivermectin treatment at three, eight and thirteen weeks after turn out. Contamination of the pasture was established by experimentally infected seeder calves. Twenty calves were split into two groups. Ten calves of one group received a bolus at the start of the experiment. In the other group the calves were treated with ivermectin at 21, 56 and 91 days. Two principal calves from each group were killed during the experiment to study histopathological changes. Pairs of tracer calves were introduced on both pastures at intervals of four weeks throughout the grazing period. The permanent calves were challenged with lungworm larvae at housing and slaughtered four weeks later. Both systems prevented parasitic bronchitis. Larval output was completely reduced in the ivermectin-treated calves while all bolus-treated calves excreted larvae at certain times. The highest group average was 4 larvae per gram faeces. Eosinophilia, ELISA-titres and histopathological changes confirmed the differences in larval uptake. Challenge infection was not successful in either group and no worms were found at slaughter. Weight gain was significantly different at housing in favour of the ivermectin-treated calves, but after challenge this was reduced due to a higher weight gain in the bolus-treated calves. The practical consequences of the results have been discussed.     

Control of gastrointestinal strongylids in first year calves: use of Paratect Flex bolus at late pasture turnout]

The efficacy of the Paratect Flex-Bolus for the control of parasitic gastroenteritis in calves was evaluated in a field experiment in the Swiss midland region. The bolus was administered to 9 first year grazing calves at 4 to 5 months of age before turnout on June 26 while 9 calves remained as untreated controls. Both groups were rotated between 8 paddocks that had been pregrazed by older cattle in spring. For a period of 12 weeks the faecal egg output of the treated calves was reduced significantly (p < 0.05) compared to the controls, whereas no significant differences were observed in the mean serum pepsinogen values of both groups. At the end of the experiment (November 14) the bolus-treated calves showed a 4 kg weight gain advantage over the controls which was not significant. The mild infection levels in both groups were probably due to the low pasture contamination with infective larvae throughout the season which most likely resulted from the late turnout of the calves. An outbreak of dictyocaulosis was observed in both groups in October and confirmed that the Paratect Flex-Bolus provides insufficient protection against this infection.     

Effects of the fenbendazole SR bolus on Trichostrongylus infections in young calves during two consecutive grazing periods

A two-year study was conducted in northern Germany to investigate the effects of the fenbendazole slow release (SR) bolus on trichostrongyle infections in cattle. Two groups of dairy replacement calves were either given a bolus at their first turncut on pasture or treated with fenbendazole suspension twice in mid-summer and at housing. Bolus-treated and control animals were set stocked on separate pastures during their first grazing season (26 weeks) and grazed together during the second year (24 weeks). During the first season the bolus prevented substantially the output of strongyle eggs for more than four months resulting in a lower infection risk in late summer and autumn as compared to the control group. The plasma pepsinogen concentrations remained low in the bolus-treated cattle during their first grazing period but rose in the controls soon after turnout which indicated increasing trichostrongyle-caused damages of the abomasal mucosa. During the following housing period and the second grazing season the bolus-treated animals showed higher egg counts than the controls. No clinical sign of parasitic gastroenteritis and no patent lungworm infections were observed during the study. The bolus-treated cattle performed better than the control animals during both grazing seasons although the control group had compensated temporarily the group difference in weight gains during the housing period. In conclusion, the use of the fenbendazole SR bolus may impair the development of immunity to trichostrongyle infections to some extent but, under the present conditions, this does not seem of clinical or economic importance.     

Use of an oxfendazole pulse release bolus in the control of parasitic gastroenteritis and parasitic bronchitis in first-season grazing calves

The efficacy of the oxfendazole pulse release bolus system for the control of parasitic gastroenteritis and parasitic bronchitis in first-season grazing calves was evaluated in Belgium. Twenty-two calves were allocated to two groups. The calves in one group received a bolus at the time of turn out, while the other group remained untreated. The efficacy of the bolus was assessed by comparison of faecal worm egg counts, plasma pepsinogen concentrations, the antibody response to Ostertagia, Cooperia and Dictyocaulus species total plasma protein and albumin concentrations, and weight gains throughout the grazing season and the housing period. The oxfendazole pulse release bolus provided good control of parasitic gastroenteritis dominated by ostertagia. The effects of parasitic gastritis were greatly reduced as shown by the significantly lower values of serum pepsinogen and ostertagia antibody titres. The use of the bolus further reduced the adverse effects of parasitism as indicated by better liveweight gains and normal total plasma protein and albumin concentrations whereas in the untreated control group hypoproteinaemia and hypoalbuminaemia were observed. Most animals exhibited clinical signs of parasitic bronchitis at the end of the grazing season, and the bolus may not adequately control parasitic bronchitis in all cases at all times.     

The effectiveness of the new morantel sustained-release trilaminate bolus against gastrointestinal nematode infections in cattle in their first grazing period

The efficacy of a recently developed Morantel-Sustained-Release-Trilaminate-Bolus (Paratect Flex Bolus [PFB]-Pfizer Inc.) against gastrointestinal nematode infections in cattle was assessed by monitoring faecal egg counts (EpG), herbage larval counts, serum pepsinogen levels and liveweight gains in first season calves. In two field trials (1987 and 1988), a PFB-Bolus was administered to two different groups of animals (1987: 15 calves; 1988:13 calves) at turnout (29 May 1987; 26 May 1988), control groups were included. In 1988, 13 calves received for comparison an Oxfendazole-Release-Bolus (Systamex Intervall Bolus [OXF]-Coopers Inc.). All groups were grazed on adjacent but separately fenced pastures throughout the season, until housing (27 October 1987; 15 October 1988). When compared with controls, the PFB-groups showed significantly lower EpG values and consequently, lower herbage larval counts throughout the season in both trials. From day 30 after turnout, the PFB-group had significantly lower serum pepsinogen levels, which reflects the low degree of abomasal damage in these animals. When compared to controls, the PFB-treated animals showed significantly higher weight performances. The mean weight-gain benefit of PFB-treated animals was +12.5 kg (p less than 0.05) and +21.1 kg (p less than 0.005) in 1987 and 1988, resp. No difference occurred between PFB-treated and OXF-treated calves, the latter outperformed the control animals by +21.6 kg (p less than 0.005).     

Epidemiology of trichostrongylidosis in cattle: development of infective larvae in the second part of the grazing period and their contribution to infections in the same year.

A grazing experiment was performed in the Swiss midland region with 22 first-season calves which were grazed together from May to mid July when they were allocated to two equal groups, one receiving a morantel sustained-release trilaminate bolus (Paratect Flex) bolus, Pfizer, Zurich, Switzerland) and the other one remaining as an untreated control. Each group was moved to a clean pasture on 21 July. The larval contamination on the pasture with the control animals reached 4652 third stage larvae (L3) per kilogram of dry matter (L3 kg-1 DM) after 10 weeks. Parasitic gastroenteritis was observed in two calves of the control group in August, and mean serum pepsinogen levels exceeded 4000 mU tyrosine in this group in September. Eggs from Ostertagia sp. and Cooperia sp. that were excreted by the animals at the beginning of July and the end of August showed similar hatching rates of 94% and 99%, respectively. In the calves of the bolus group the egg output was reduced by 95% within 14 days of administration of the bolus. Larval contamination on the pasture of the bolus group was zero until the beginning of September when a slight increase occurred, reaching 793 L3 kg-1 DM in October. At the end of the trial the bolus-treated calves had a mean weight gain advantage of 18 kg (P < 0.05) compared with the controls. The results confirm that a second generation of larvae developed on pasture in August and September and caused parasitic gastroenteritis in first-year grazing calves in late summer. The relevance of the results for the prophylaxis of parasitic gastroenteritis in calves in mixed grazing systems with calves and older cattle is discussed.     

Serum pepsinogen levels to monitor gastrointestinal nematode infections in cattle revisited

The serum pepsinogen level is widely accepted as a useful parameter for monitoring gastrointestinal nematode infections in first-season grazing calves. However, several aspects, with possible implications for its practicality and the way to use the pepsinogen test, have received little attention to date. The objectives of this study were to evaluate (1) the reproducibility of a pepsinogen assay; (2) the required sample size for a reliable diagnosis and (3) the compliance to and effect of advice based on pepsinogen levels determined in year one on the nematode infection levels in the next generation of calves. Despite a high repeatability of the pepsinogen assay within the reference lab, the reproducibility between different labs was poor. There was more variation in pepsinogen levels between herds than between animals within a herd, suggesting that it is most useful to make a herd level diagnosis. Sample size calculation indicated that sampling seven animals sufficed to obtain a reliable indication of calf groups of up to 40 animals. Eighty-two herds were followed-up over two consecutive years and 39 (48%) had followed the advice that was formulated based on pepsinogen levels. Thirty-nine percent of the herds were advised to reduce the intensity of chemoprophylaxis. Samples from animals of those herds showed a higher pepsinogen level in the second year, but none of them had a mean pepsinogen level that is considered excessive. It is concluded that pepsinogen determination at housing from a limited number of animals can contribute to the design of the anthelmintic control strategy in the next year and a more targeted use of anthelmintics. However, more efforts are needed to harmonize the assay between veterinary diagnostic labs.     

Efficacy of morantel sustained release bolus against gastrointestinal nematodes in first season grazing Holstein calves

The efficacy of the morantel sustained release bolus (MSRB) in reducing gastrointestinal parasitism in first season grazing calves was evaluated during the summer--autumn grazing seasons of 1982 and 1983 in western Oregon. Each of 38 calves (1982) and 40 calves (1983) were randomly assigned to either control or treatment groups which were given MSRB on the day of turnout onto pasture. Mean worm burdens from tracer calves grazed with treated animals in 1982 and 1983 showed overall reductions of 86.4% (P greater than 0.05) and 84.3% (P less than 0.01), respectively, compared to tracers grazed with controls. Ostertagia ostertagi, Cooperia oncophora and Nematodirus helvetianus were the primary nematodes collected at necropsy. Twelve full-season 1982 tracer animals (6 treated and 6 control) indicated an 88.1% (P less than 0.05) overall reduction in mean worm burdens. Mean fecal worm egg per gram (EPG) counts of treated animals reflected a reduction of 69% (P less than 0.05) in 1982 and 90% (P less than 0.05) in 1983. Autumn inhibition of O. ostertagi was observed. In the 1982 trial the control animals showed a slight mean weight gain advantage over the treated group from Day 84 until Day 160 (trial termination) when the mean difference was 7.9 kg. The final mean weight gain advantage of treated animals in 1983 was 13.5 kg (P less than 0.05). These trials demonstrated that the MSRB was an effective anthelmintic for reducing gastrointestinal parasitism in grazing calves and for decreasing pasture larval contamination.     

Effect of nematode infections on growth performance of calves after stabling on commercial dairy farms

Growth performance of calves was assessed on 32 farms during winter housing. Nematode infection was measured by antibody titres, pepsinogen values, and faecal examinations. Half of each herd was treated with ivermectin after stabling. Treatment significantly increased growth rate by an average of +0.059 kg day-1 (P less than 0.01). The effect of treatment varied among herds from -0.078 to +0.210 kg day-1. Only a few of the infection parameters correlated weakly, but positively, to the effect of treatment on growth performance per herd. Untreated control groups showed very different growth rates among herds, ranging from 0.250 to 0.936 kg day-1. This was strongly correlated to several infection parameters. Groups with the highest values for the infection parameters gained approximately 50 kg less over a 4-month period during winter housing than groups with the lowest values for those infection parameters.